Table 4.
Comparison of serum biomarkers and DECAF score of exacerbated patients: survived versus dead patients and non-intubated versus intubated patients
Parameter | Survived patients (n=60) | Patients who died (n=2) | P-value |
---|---|---|---|
PCT (ng/mL) | 0.11 (0.03–19.29) | 1.175 (0.47–1.88) | 0.121 |
CRP (mg/L) | 25.37 (1–700) | 76.53 (67–85) | 0.233 |
DECAF score | 2 (1–5) | 2 (2–2) | 0.401 |
| |||
Parameter | Non-intubated patients (n=57) | Intubated patients (n=5) | P-value |
| |||
PCT (ng/mL) | 0.11 (0.03–19.29) | 0.38 (0.06–0.47) | 0.373 |
CRP (mg/L) | 26.79 (1–700) | 37.46 (10–67) | 0.867 |
DECAF score | 2 (1–5) | 2 (2–4) | 0.822 |
Note: Data were presented as median (range).
Abbreviations: DECAF, dyspnea, eosinopenia, consolidation, acidemia, and atrial fibrillation; PCT, procalcitonin; CRP, C-reactive protein.